血清hs-CRP CysC水平在缺血性脑卒中中的作用的研究进展
Research Progress on the Role of Serum hs-CRP and CysC Levels in Ischemic Stroke
DOI: 10.12677/jcpm.2024.32081, PDF,   
作者: 高 杨：青海大学研究生院，青海 西宁；侯 倩*：青海省人民医院神经内科，青海 西宁
关键词: 超敏C反应蛋白；胱抑素C；缺血性脑卒中；High-Sensitivity C-Reactive Protein； Cystatin C； Ischemic Stroke
摘要: 本综述探讨了超敏C反应蛋白(hs-CRP)和胱抑素C (CysC)在缺血性脑卒中中的作用及其作为疾病预测标志物和治疗靶点的潜力。研究显示，hs-CRP作为炎症标志物，其水平升高与缺血性脑卒中风险增加、病情严重度及不良预后相关；CysC不仅反映肾功能，还在神经保护和脑卒中恢复中发挥作用，提示其在预测及治疗缺血性脑卒中中的潜在价值，强调了进一步研究这些生物标记物在缺血性脑卒中管理中应用的重要性。
Abstract: This review discusses the roles of high-sensitivity C-reactive protein (hs-CRP) and Cystatin C (CysC) in ischemic stroke, as well as their potential as predictive biomarkers and therapeutic targets for the disease. Studies have shown that hs-CRP, as an inflammation marker, is associated with an increased risk of ischemic stroke, severity of the condition, and poor prognosis. CysC not only reflects kidney function but also plays a role in neuroprotection and stroke recovery, indicating its potential value in predicting and treating ischemic stroke. The importance of further research into the application of these biomarkers in the management of ischemic stroke is emphasized.
文章引用：高杨, 侯倩. 血清hs-CRP CysC水平在缺血性脑卒中中的作用的研究进展[J]. 临床个性化医学, 2024, 3(2): 556-563. https://doi.org/10.12677/jcpm.2024.32081

参考文献

[1] Lin, X., Yu, C., Ding, H., Ma, X., Guo, F., Chen, D., et al. (2022) The Study of Serum C-Reactive Protein, Serum Cystatin C, and Carbohydrate Antigen 125 in Patients with Acute Ischemic Stroke. Cellular and Molecular Biology, 68, 89-95. [Google Scholar] [CrossRef] [PubMed]
[2] Brambila-Tapia, A.J.L., Jacquez-Castañeda, A.L., Carrillo-Delgadillo, L.A., Dávila-Flores, J.N., Macías-Espinoza, F., Ramírez-De Los Santos, S., et al. (2023) Association between Psychological, Biochemical and Personal Factors with the Inflammatory Marker High-Sensitive C Reactive Protein (Hs-CRP) in Mexican Healthy Population. Journal of Personalized Medicine, 13, Article 876. [Google Scholar] [CrossRef] [PubMed]
[3] Coveney, S., Murphy, S., Belton, O., Cassidy, T., Crowe, M., Dolan, E., et al. (2021) Inflammatory Cytokines, High-Sensitivity C-Reactive Protein, and Risk of One-Year Vascular Events, Death, and Poor Functional Outcome after Stroke and Transient Ischemic Attack. International Journal of Stroke, 17, 163-171. [Google Scholar] [CrossRef] [PubMed]
[4] Lee, S., Song, I., Na, S., Jeong, D. and Chung, S. (2020) Association between Long-Term Functional Outcome and Change in Hs-CRP Level in Patients with Acute Ischemic Stroke. The Neurologist, 25, 122-125. [Google Scholar] [CrossRef] [PubMed]
[5] Cabarkapa, V. (2015) Cystatin C—More than the Marker of the Glomerular Filtration Rate. Medical Review, 68, 173-179. [Google Scholar] [CrossRef] [PubMed]
[6] 沈慧楠, 郭畅, 孙艺萌, 王东玉. 胱抑素C对血管性帕金森综合征的诊断效能[J]. 临床荟萃, 2021, 36(11): 986-990.
[7] Chu, M., Luo, Y., Wang, D., Liu, Z., Niu, H., Wu, X., et al. (2024) Prediction of Poststroke Cognitive Impairment Based on the Systemic Inflammatory Response Index. Brain and Behavior, 14, e3372. [Google Scholar] [CrossRef] [PubMed]
[8] Liu, F., Yang, P., Wang, Y., Shi, M., Wang, R., Xu, Q., et al. (2023) HS-CRP Modifies the Prognostic Value of Platelet Count for Clinical Outcomes after Ischemic Stroke. Journal of the American Heart Association, 12, e030007. [Google Scholar] [CrossRef] [PubMed]
[9] Niu, H., Jiang, R., Dong, S., Xia, L. and Fang, H. (2021) Research on Association between Levels of Serum Adiponectin, Hs-CRP, and sICAM-1 and Hypertensive Cerebrovascular Complications. BioMed Research International, 2021, Article 4455038. [Google Scholar] [CrossRef] [PubMed]
[10] Dix, C., Zeller, J., Stevens, H., Eisenhardt, S.U., Shing, K.S.C.T., Nero, T.L., et al. (2022) C-Reactive Protein, Immunothrombosis and Venous Thromboembolism. Frontiers in Immunology, 13, Article 1002652. [Google Scholar] [CrossRef] [PubMed]
[11] Zuo, L., Dong, Y., Pan, Y., Yan, H., Meng, X., Li, H., et al. (2023) Impact of Serum Cystatin C Level on Long-Term Cognitive Impairment after Acute Ischemic Stroke and Transient Ischemic Attack. Neuropsychiatric Disease and Treatment, 19, 1543-1554. [Google Scholar] [CrossRef] [PubMed]
[12] Zhang, Y. and Sun, L. (2018) Cystatin C in Cerebrovascular Disorders. Current Neurovascular Research, 14, 406-414. [Google Scholar] [CrossRef] [PubMed]
[13] Zhu, Z., Zhong, C., Xu, T., Wang, A., Peng, Y., Xu, T., et al. (2018) Prognostic Significance of Serum Cystatin C in Acute Ischemic Stroke Patients According to Lipid Component Levels. Atherosclerosis, 274, 146-151. [Google Scholar] [CrossRef] [PubMed]
[14] Yan, X., Chen, H. and Shang, X. (2022) Association between Serum Cystatin C Level and Post-Stroke Cognitive Impairment in Patients with Acute Mild Ischemic Stroke. Brain and Behavior, 12, e2519. [Google Scholar] [CrossRef] [PubMed]
[15] Liu, W., Zhu, X., Tan, X., Yang, L., Wang, Y., Diao, S., et al. (2021) Predictive Value of Serum Creatinine/Cystatin C in Acute Ischemic Stroke Patients under Nutritional Intervention. The Journal of Nutrition, Health and Aging, 25, 335-339. [Google Scholar] [CrossRef] [PubMed]
[16] Xu, Z., Leng, C., Yang, B., Wang, H., Sun, J., Liu, Z., et al. (2017) Serum Cystatin C Is Associated with Large Cerebral Artery Stenosis in Acute Ischemic Stroke. Oncotarget, 8, 67181-67188. [Google Scholar] [CrossRef] [PubMed]
[17] Pérez-González, R., Sahoo, S., Gauthier, S.A., Kim, Y., Li, M., Kumar, A., et al. (2019) Neuroprotection Mediated by Cystatin C-Loaded Extracellular Vesicles. Scientific Reports, 9, Article No. 11104. [Google Scholar] [CrossRef] [PubMed]
[18] Fang, Z., Deng, J., Wu, Z., Dong, B., Wang, S., Chen, X., et al. (2017) Cystatin C Is a Crucial Endogenous Protective Determinant against Stroke. Stroke, 48, 436-444. [Google Scholar] [CrossRef] [PubMed]
[19] Wang, L., Wu, L., Lang, Y., Wu, D., Chen, J., Zhao, W., et al. (2020) Association between High-Sensitivity C-Reactive Protein Levels and Clinical Outcomes in Acute Ischemic Stroke Patients Treated with Endovascular Therapy. Annals of Translational Medicine, 8, 1379-1379. [Google Scholar] [CrossRef] [PubMed]
[20] Pu, Y., Li, S., Wang, L., Fang, B. and Bai, X. (2022) Association between High-Sensitivity C-Reactive Protein and Prognosis of Patients with Acute Cerebral Infarction. Neuropsychiatric Disease and Treatment, 18, 1771-1778. [Google Scholar] [CrossRef] [PubMed]
[21] Jia, M., Shi, Y., Wang, Y., Wang, M., Zhang, L., He, Q., et al. (2022) High-Sensitivity C-Reactive Protein and Ischemic Stroke in Patients with Nonalcoholic Fatty Liver Disease: A Prospective Study. Journal of Healthcare Engineering, 2022, Article 9711712. [Google Scholar] [CrossRef] [PubMed]
[22] Wang, S., Song, X., Wang, Y., Gao, Y. and Wu, J. (2021) Elevated High-Sensitivity C-Reactive Protein Levels Predict Poor Outcomes among Patients with Acute Cardioembolic Stroke. Annals of Palliative Medicine, 10, 2907-2916. [Google Scholar] [CrossRef] [PubMed]
[23] Gu, H., Yang, K., Lin, J., Jing, J., Zhao, X., Wang, Y., et al. (2022) Association between High-Sensitivity C-Reactive Protein, Functional Disability, and Stroke Recurrence in Patients with Acute Ischaemic Stroke: A Mediation Analysis. eBioMedicine, 80, Article 104054. [Google Scholar] [CrossRef] [PubMed]
[24] Wang, Y., Li, J., Pan, Y., Wang, M., Meng, X. and Wang, Y. (2022) Association between High-Sensitivity C-Reactive Protein and Prognosis in Different Periods after Ischemic Stroke or Transient Ischemic Attack. Journal of the American Heart Association, 11, e025464. [Google Scholar] [CrossRef] [PubMed]
[25] Ding, Y., Liu, L., Chen, Z., Li, H., Pan, Y., Wang, J., et al. (2021) Serum Cystatin C Predicts Stroke Clinical Outcomes at 1 Year Independent of Renal Function. Frontiers in Neurology, 12, Article 676872. [Google Scholar] [CrossRef] [PubMed]
[26] Malmgren, L., McGuigan, F.E., Christensson, A. and Akesson, K.E. (2022) Impaired Selective Renal Filtration Captured by eGFRcysC/eGFRcrea Ratio Is Associated with Mortality in a Population Based Cohort of Older Women. Scientific Reports, 12, Article No. 1273. [Google Scholar] [CrossRef] [PubMed]
[27] Selvi, E., Aybal Kutlugun, A., Tangal, N.G., Murat, K., Akkan, T., Beyan, E., et al. (2021) Relationship between Renal Volume and Atherosclerosis in Nondiabetic Hypertensive Patients with Normal Glomerular Filtration Rate. Clinical and Experimental Hypertension, 43, 373-377. [Google Scholar] [CrossRef] [PubMed]
[28] Su, M., Zhou, Y., Chen, Z., Pu, M., Li, Z., Du, H., et al. (2021) Cystatin C Predicts Futile Recanalization in Patients with Acute Ischemic Stroke after Endovascular Treatment. Journal of Neurology, 269, 966-972. [Google Scholar] [CrossRef] [PubMed]
[29] Ma, Y., Li, C., Hua, R., et al. (2023) Association between Serum Cystatin C and Cognitive Decline Independently from Creatinine: Evidence from Two Nationally Representative Aging Cohorts. Journal of Alzheimer’s Disease, 93, 459-469. [Google Scholar] [CrossRef] [PubMed]
[30] Ren, J., Dong, X. and Nao, J. (2020) Serum Cystatin C Is Associated with Carotid Atherosclerosis in Patients with Acute Ischemic Stroke. Neurological Sciences, 41, 2793-2800. [Google Scholar] [CrossRef] [PubMed]
[31] Liu, H., Qian, S., Zhong, C., Wang, A., Peng, Y., Peng, H., et al. (2021) Predictive Value of Cystatin C for Stroke Recurrence in Patients with Acute Ischemic Stroke. Circulation Journal, 85, 213-219. [Google Scholar] [CrossRef] [PubMed]